Report Detail

Request for Sample of this report

Pharma & Healthcare Global Antiserum Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4668477
    • |
  • 22 January, 2026
    • |
  • Global
    • |
  • 119 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Antiserum market size was valued at US$ 1665 million in 2025 and is forecast to a readjusted size of US$ 2605 million by 2032 with a CAGR of 6.7% during review period.
Antiserum, a type of blood serum that contains specific antibodies against an antigen (foreign agent), such as an infective organism or poisonous substance. Antibodies in antiserum work by detecting and subsequently neutralizing antigens. Antiserums are produced in animals, most commonly horses, sheep, oxen, and rabbits, and in humans, in response to infection, intoxication, or vaccination. Animal and human antiserums can be used in other individuals to confer immunity to a specific disease or to treat bites or stings of venomous animals. Antiserum widely used in diagnostic virology laboratories. The most common use of antiserum in humans is as antitoxin or antivenom to treat envenomation.
The Antiserum market belongs to the pharmaceutical industry, and its development is closely related to economic development and people's quality of life. Antiserum is used in the treatment of snake venom, rabies, tetanus, etc. and bacterial detection. The market potential is huge. Policy support and emphasis on food and water safety are the main factors promoting market development.
Product safety risks, high industry barriers, high safety requirements, and stricter market regulation are the main factors hindering market development.
In terms of regional development, at present, the sources of market supply are mainly concentrated in North America. With the technological development and progress of Asian countries, in the future, we can focus on the development trend of Asian regions.
In terms of market competition, due to the higher technical barriers and stricter regulation of biopharmaceuticals, the market competition is relatively mild.
The major global companies of Antiserum include CSL，Merck，BTG，Pfizer，CNBG and etc. The top five vendors held 59% of the market.
In the future, with the continuous development of the market and the increase of new entrants, relevant companies need to fully promote the clinical research and preclinical research of new products, and at the same time continue to research and explore, and strive to achieve technological innovation and breakthroughs in existing products and improve product quality compete with safe, effective, economical and suitable product differentiation, and avoid being eliminated by the continuously developing market.
This report is a detailed and comprehensive analysis for global Antiserum market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Antiserum market size and forecasts, in consumption value ($ Million), 2021-2032
Global Antiserum market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Antiserum market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Antiserum market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antiserum
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antiserum market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL, Merck, BTG, Pfizer, CNBG, Bharat Serums and Vaccines, Haffkine Bio-Pharmaceutical, Serum Biotech, Bio-Rad, BD, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Antiserum market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Antitoxin Serum
Antibacterial Serum
Antiviral Serum
Others
Market segment by Application
Clinical
Laboratory
Market segment by players, this report covers
CSL
Merck
BTG
Pfizer
CNBG
Bharat Serums and Vaccines
Haffkine Bio-Pharmaceutical
Serum Biotech
Bio-Rad
BD
Vins Bioproducts
FUJIFILM Wako Pure Chemical Corporation
SSI Diagnostica
GD Animal Health
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Antiserum product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antiserum, with revenue, gross margin, and global market share of Antiserum from 2021 to 2026.
Chapter 3, the Antiserum competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Antiserum market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antiserum.
Chapter 13, to describe Antiserum research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Antiserum by Type
    • 1.3.1 Overview: Global Antiserum Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Antiserum Consumption Value Market Share by Type in 2025
    • 1.3.3 Antitoxin Serum
    • 1.3.4 Antibacterial Serum
    • 1.3.5 Antiviral Serum
    • 1.3.6 Others
  • 1.4 Global Antiserum Market by Application
    • 1.4.1 Overview: Global Antiserum Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Clinical
    • 1.4.3 Laboratory
  • 1.5 Global Antiserum Market Size & Forecast
  • 1.6 Global Antiserum Market Size and Forecast by Region
    • 1.6.1 Global Antiserum Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Antiserum Market Size by Region, (2021-2032)
    • 1.6.3 North America Antiserum Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Antiserum Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Antiserum Market Size and Prospect (2021-2032)
    • 1.6.6 South America Antiserum Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Antiserum Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 CSL
    • 2.1.1 CSL Details
    • 2.1.2 CSL Major Business
    • 2.1.3 CSL Antiserum Product and Solutions
    • 2.1.4 CSL Antiserum Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 CSL Recent Developments and Future Plans
  • 2.2 Merck
    • 2.2.1 Merck Details
    • 2.2.2 Merck Major Business
    • 2.2.3 Merck Antiserum Product and Solutions
    • 2.2.4 Merck Antiserum Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Merck Recent Developments and Future Plans
  • 2.3 BTG
    • 2.3.1 BTG Details
    • 2.3.2 BTG Major Business
    • 2.3.3 BTG Antiserum Product and Solutions
    • 2.3.4 BTG Antiserum Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 BTG Recent Developments and Future Plans
  • 2.4 Pfizer
    • 2.4.1 Pfizer Details
    • 2.4.2 Pfizer Major Business
    • 2.4.3 Pfizer Antiserum Product and Solutions
    • 2.4.4 Pfizer Antiserum Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Pfizer Recent Developments and Future Plans
  • 2.5 CNBG
    • 2.5.1 CNBG Details
    • 2.5.2 CNBG Major Business
    • 2.5.3 CNBG Antiserum Product and Solutions
    • 2.5.4 CNBG Antiserum Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 CNBG Recent Developments and Future Plans
  • 2.6 Bharat Serums and Vaccines
    • 2.6.1 Bharat Serums and Vaccines Details
    • 2.6.2 Bharat Serums and Vaccines Major Business
    • 2.6.3 Bharat Serums and Vaccines Antiserum Product and Solutions
    • 2.6.4 Bharat Serums and Vaccines Antiserum Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Bharat Serums and Vaccines Recent Developments and Future Plans
  • 2.7 Haffkine Bio-Pharmaceutical
    • 2.7.1 Haffkine Bio-Pharmaceutical Details
    • 2.7.2 Haffkine Bio-Pharmaceutical Major Business
    • 2.7.3 Haffkine Bio-Pharmaceutical Antiserum Product and Solutions
    • 2.7.4 Haffkine Bio-Pharmaceutical Antiserum Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Haffkine Bio-Pharmaceutical Recent Developments and Future Plans
  • 2.8 Serum Biotech
    • 2.8.1 Serum Biotech Details
    • 2.8.2 Serum Biotech Major Business
    • 2.8.3 Serum Biotech Antiserum Product and Solutions
    • 2.8.4 Serum Biotech Antiserum Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Serum Biotech Recent Developments and Future Plans
  • 2.9 Bio-Rad
    • 2.9.1 Bio-Rad Details
    • 2.9.2 Bio-Rad Major Business
    • 2.9.3 Bio-Rad Antiserum Product and Solutions
    • 2.9.4 Bio-Rad Antiserum Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Bio-Rad Recent Developments and Future Plans
  • 2.10 BD
    • 2.10.1 BD Details
    • 2.10.2 BD Major Business
    • 2.10.3 BD Antiserum Product and Solutions
    • 2.10.4 BD Antiserum Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 BD Recent Developments and Future Plans
  • 2.11 Vins Bioproducts
    • 2.11.1 Vins Bioproducts Details
    • 2.11.2 Vins Bioproducts Major Business
    • 2.11.3 Vins Bioproducts Antiserum Product and Solutions
    • 2.11.4 Vins Bioproducts Antiserum Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Vins Bioproducts Recent Developments and Future Plans
  • 2.12 FUJIFILM Wako Pure Chemical Corporation
    • 2.12.1 FUJIFILM Wako Pure Chemical Corporation Details
    • 2.12.2 FUJIFILM Wako Pure Chemical Corporation Major Business
    • 2.12.3 FUJIFILM Wako Pure Chemical Corporation Antiserum Product and Solutions
    • 2.12.4 FUJIFILM Wako Pure Chemical Corporation Antiserum Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 FUJIFILM Wako Pure Chemical Corporation Recent Developments and Future Plans
  • 2.13 SSI Diagnostica
    • 2.13.1 SSI Diagnostica Details
    • 2.13.2 SSI Diagnostica Major Business
    • 2.13.3 SSI Diagnostica Antiserum Product and Solutions
    • 2.13.4 SSI Diagnostica Antiserum Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 SSI Diagnostica Recent Developments and Future Plans
  • 2.14 GD Animal Health
    • 2.14.1 GD Animal Health Details
    • 2.14.2 GD Animal Health Major Business
    • 2.14.3 GD Animal Health Antiserum Product and Solutions
    • 2.14.4 GD Animal Health Antiserum Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 GD Animal Health Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Antiserum Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Antiserum by Company Revenue
    • 3.2.2 Top 3 Antiserum Players Market Share in 2025
    • 3.2.3 Top 6 Antiserum Players Market Share in 2025
  • 3.3 Antiserum Market: Overall Company Footprint Analysis
    • 3.3.1 Antiserum Market: Region Footprint
    • 3.3.2 Antiserum Market: Company Product Type Footprint
    • 3.3.3 Antiserum Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Antiserum Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Antiserum Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Antiserum Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Antiserum Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Antiserum Consumption Value by Type (2021-2032)
  • 6.2 North America Antiserum Market Size by Application (2021-2032)
  • 6.3 North America Antiserum Market Size by Country
    • 6.3.1 North America Antiserum Consumption Value by Country (2021-2032)
    • 6.3.2 United States Antiserum Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Antiserum Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Antiserum Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Antiserum Consumption Value by Type (2021-2032)
  • 7.2 Europe Antiserum Consumption Value by Application (2021-2032)
  • 7.3 Europe Antiserum Market Size by Country
    • 7.3.1 Europe Antiserum Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Antiserum Market Size and Forecast (2021-2032)
    • 7.3.3 France Antiserum Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Antiserum Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Antiserum Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Antiserum Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Antiserum Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Antiserum Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Antiserum Market Size by Region
    • 8.3.1 Asia-Pacific Antiserum Consumption Value by Region (2021-2032)
    • 8.3.2 China Antiserum Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Antiserum Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Antiserum Market Size and Forecast (2021-2032)
    • 8.3.5 India Antiserum Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Antiserum Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Antiserum Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Antiserum Consumption Value by Type (2021-2032)
  • 9.2 South America Antiserum Consumption Value by Application (2021-2032)
  • 9.3 South America Antiserum Market Size by Country
    • 9.3.1 South America Antiserum Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Antiserum Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Antiserum Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Antiserum Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Antiserum Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Antiserum Market Size by Country
    • 10.3.1 Middle East & Africa Antiserum Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Antiserum Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Antiserum Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Antiserum Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Antiserum Market Drivers
  • 11.2 Antiserum Market Restraints
  • 11.3 Antiserum Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Antiserum Industry Chain
  • 12.2 Antiserum Upstream Analysis
  • 12.3 Antiserum Midstream Analysis
  • 12.4 Antiserum Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Antiserum. Industry analysis & Market Report on Antiserum is a syndicated market report, published as Global Antiserum Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Antiserum market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo